Skip to main content
. 2018 Sep 19;9(5):880–897. doi: 10.1002/jcsm.12316

Table 1.

Characteristics of PLX PAD cells in comparison to BM MSC

Marker PLX‐PAD BM MSC PLX‐PAD BM MSC Marker PLX‐PAD BM MSC PLX‐PAD BM MSC
CD1a 0.91 1.08 CD104 1.03 1.00
CD1b 1.07 1.05 CD105 33.60 18.31 + +
CD1d 1.00 1.35 CD106 0.98 1.05
CD2 0.92 1.11 CD107a 2.26 7.17
CD3 0.93 1.15 CD108 53.72 12.24 + +
CD4 0.98 1.14 CD109 1.80 11.18 +
CD5 0.96 1.14 CD112 1.65 15.55 +
CD6 1.01 1.11 CD114 0.95 0.97
CD7 0.99 1.11 CD116 1.50 0.90
CD8a 0.98 1.10 CD117 0.93 1.04
CD9 21.04 95.75 + + CD119 2.05 2.11
CD10 11.07 7.87 + CD122 1.01 0.84
CD11a 1.04 1.02 CD123 1.10 0.79
CD11b 0.92 1.06 CD124 1.02 1.09
CD11c 0.92 1.11 CD126 1.03 1.02
CD13 55.07 217.92 + ++ CD127 1.64 1.01
CD14 0.99 1.15 CD132 1.03 1.56
CD15 0.97 1.13 CD134 0.97 1.22
CD16 0.95 1.08 CD135 1.02 1.04
CD18 0.96 1.15 CD137 0.96 1.15
CD19 0.94 1.09 CD137L 0.96 1.71
CD20 0.97 0.90 CD138 1.29 1.62
CD21 0.91 1.02 CD140a 2.79 2.44
CD22 0.91 1.00 CD140b 20.26 2.37 +
CD23 0.92 1.06 CD141 1.08 1.77
CD24 1.07 1.14 CD144 26.88 1.25 +
CD25 0.95 0.93 CD146 17.08 14.29 + +
CD26 1.85 1.81 CD150 20.86 1.05 +
CD27 1.00 1.05 CD152 1.07 1.01
CD28 0.97 1.12 CD154 0.97 44.83 +
CD29 42.31 268.79 + ++ CD158a 0.99 1.05
CD30 0.96 1.11 CD158b 1.00 1.02
CD31 0.88 1.13 CD161 0.99 1.11
CD32 0.94 1.18 CD162 1.09 1.24
CD33 0.89 1.24 CD163 1.06 0.88
CD34 0.98 1.13 CD164 12.23 29.09 + +
CD35 0.91 1.06 CD165 6.66 6.63
CD36 0.97 1.27 CD166 27.19 123.63 + ++
CD38 0.98 1.22 CD172b 1.13 0.77
CD39 0.98 1.25 CD178 1.01 0.94
CD40 1.05 1.22 CD180 0.97 1.05
CD41 1.05 1.12 CD181 1.06 1.73
CD42b 0.93 1.17 CD183 1.02 1.96
CD43 0.92 1.53 CD184 1.01 1.81
CD44 454.30 536.28 ++ ++ CD193 1.28 3.53
CD45 1.19 1.00 CD195 0.99 1.06
CD45RA 0.99 0.96 CD196 1.00 2.22
CD45RB 0.95 0.82 CD197 0.96 1.05
CD45RO 0.99 0.97 CD200 1.00 1.85
CD46 29.60 2.47 + CD201 3.51 5.55
CD47 30.72 32.72 + + CD205 0.98 1.17
CD48 0.97 1.29 CD206 0.98 0.79
CD49a 27.69 3.58 + CD209 1.09 0.78
CD49c 71.64 75.68 + + CD210 1.04 1.00
CD49d 27.06 5.66 + CD220 1.10 1.21
CD49e 67.45 91.58 + + CD221 3.94 1.98
CD49f 37.65 35.43 + + CD226 1.03 1.11
CD50 0.99 0.99 CD229 1.78 0.84
CD51 16.64 34.82 + + CD231 1.04 1.11
CD53 0.91 1.26 CD235a 1.06 1.39
CD54 9.41 9.68 CD243 1.07 1.49
CD55 77.31 12.99 + + CD244 0.96 1.08
CD56 2.73 1.41 CD255 1.03 2.08
CD57 1.10 1.01 CD267 0.99 1.02
CD58 15.91 15.72 + + CD268 1.06 0.99
CD59 122.19 1.75 ++ CD271 2.28 1.05
CD61 17.67 1.00 + CD273 18.45 9.22 +
CD62E 0.92 1.08 CD274 14.77 3.98 +
CD62L 0.95 1.16 CD275 1.03 1.09
CD62P 0.90 55.77 + CD278 1.05 0.94
CD63 24.50 352.06 + ++ CD279 0.98 1.13
CD64 0.90 1.13 CD282 0.95 0.95
CD66acde 0.94 1.13 CD294 1.02 0.97
CD66b 1.02 1.12 CD314 0.99 1.21
CD69 0.99 1.02 CD326 1.12 0.92
CD70 1.01 8.76 CDw328 0.96 0.98
CD71 13.24 26.78 + + CD335 1.01 1.05
CD73 95.12 75.35 + + CD336 0.94 1.25
CD74 1.05 1.29 CD337 0.96 1.12
CD79b 1.01 1.26 CD338 1.19 1.09
CD80 1.43 1.16 CD340 8.48 2.84
CD81 153.86 93.47 ++ + abTCR 1.07
CD83 0.94 1.49 b2 micro globulin 45.89 199.48 + ++
CD84 1.04 1.22 BLTR 0.98 1.26
CD85 1.04 1.13 EGF R 34.74 16.83 + +
CD86 0.96 0.95 HLA_A2 1.03 1.09
CD87 1.05 1.28 HLA_ABC 99.57 13.81 + +
CD88 0.99 0.74 HLA_DQ 3.24 1.04
CD89 0.93 1.13 HLA_DR 1.02 0.92
CD90 25.98 61.91 + + Integrin b7 1.00 0.90
CD93 0.98 0.96 MIC A_B 2.13 2.41
CD94 1.01 0.64 SSEA_1 0.95 0.95
CD95 25.84 17.57 + + SSEA_3 0.99 0.98
CD97 6.09 7.95 SSEA_4 3.38 7.30
CD99 10.94 203.49 + ++ TRA_1_60 0.91 1.10
CD100 1.04 1.07 TRA_1_81 1.07 1.04
CD102 1.11 0.93 Vb23 1.08 1.12
CD103 0.93 0.77 Vb8 1.01 1.05

Data are shown as x‐fold expression/MFI compared with isotype control: +++: >1000 fold; ++: >100 fold, +: >10 fold, and −: negative vs. isotype control. BM MSC: bone marrow‐derived mesenchymal stromal cells.